Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Schema
  10. Social Networks
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers
  15. CDN Services

We are analyzing https://www.nature.com/articles/4671053a.

Title:
Genomic evolution of metastasis | Nature
Description:
Prognosis for patients with pancreatic cancer is bleak, often owing to late diagnosis. The estimate that at least 15 years pass from tumour initiation to malignancy offers hope for early detection and prevention. See Letters p.1109 & p.1114 Christine Iacobuzio-Donahue and colleagues use whole-genome exome sequencing to analyse primary pancreatic cancers and one or more metastases from the same patients, and find that tumours are composed of distinct subclones. The authors also determine the evolutionary maps by which metastatic cancer clones have evolved within the primary tumour, and estimate the timescales of tumour progression. On the basis of these data, they estimate a mean period of 11.8 years between the initiation of pancreatic tumorigenesis and the formation of the parental, non-metastatic tumour, and a further 6.8 years for the index metastasis clone to arise. These data point to a potentially large window of opportunity during which it might be possible to detect the cancer in a relatively early form. Peter Campbell and colleagues use next-generation sequencing to detect chromosomal rearrangements in 13 patients with pancreatic cancer. The results reveal considerable inter-patient heterogeneity and indicate ongoing genomic instability and evolution during the development of metastases. But for most of the patients studied, more than half of the genetic rearrangements found were present in all metastases and the primary tumour, making them potential targets for therapeutic intervention at early and late stages of the disease.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Health & Fitness
  • Animals & Wildlife
  • Social Networks

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.

Keywords {πŸ”}

nature, cancer, article, access, content, cookies, pancreatic, privacy, journal, luebeck, open, cas, google, scholar, data, october, genomic, metastasis, research, advertising, information, subscribe, evolution, georg, tumour, institution, articles, buy, ads, permissions, optional, media, personal, parties, policy, journals, log, news, views, published, cite, late, early, detection, prevention, inferring, synteny, genome, assemblies, systematic,

Topics {βœ’οΈ}

nature portfolio permissions reprints privacy policy advertising social media nature 467 nature personal data springerlink instant access data protection permissions genomic instability pancreatic cancer privacy explore content subscription content european economic area malignancy offers hope martin huntΒ &Β isheng institutional subscriptions read potential clinical utility accepting optional cookies journals search log manage preferences cancer metastasis issue learn tumour initiation content access genomic evolution article luebeck article purchase journal publish article cite early detection institution buy optional cookies cancer choices late diagnosis prevention https georg luebeck essential cookies cookies skip institution subscribe articles article genetic evolution usage analysis

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Genomic evolution of metastasis
         description:Prognosis for patients with pancreatic cancer is bleak, often owing to late diagnosis. The estimate that at least 15 years pass from tumour initiation to malignancy offers hope for early detection and prevention. See Letters p.1109 & p.1114 Christine Iacobuzio-Donahue and colleagues use whole-genome exome sequencing to analyse primary pancreatic cancers and one or more metastases from the same patients, and find that tumours are composed of distinct subclones. The authors also determine the evolutionary maps by which metastatic cancer clones have evolved within the primary tumour, and estimate the timescales of tumour progression. On the basis of these data, they estimate a mean period of 11.8 years between the initiation of pancreatic tumorigenesis and the formation of the parental, non-metastatic tumour, and a further 6.8 years for the index metastasis clone to arise. These data point to a potentially large window of opportunity during which it might be possible to detect the cancer in a relatively early form. Peter Campbell and colleagues use next-generation sequencing to detect chromosomal rearrangements in 13 patients with pancreatic cancer. The results reveal considerable inter-patient heterogeneity and indicate ongoing genomic instability and evolution during the development of metastases. But for most of the patients studied, more than half of the genetic rearrangements found were present in all metastases and the primary tumour, making them potential targets for therapeutic intervention at early and late stages of the disease.
         datePublished:2010-10-27T00:00:00Z
         dateModified:2010-10-27T00:00:00Z
         pageStart:1053
         pageEnd:1055
         sameAs:https://doi.org/10.1038/4671053a
         keywords:
            Cancer genomics
            Cancer prevention
            Genomic instability
            Pancreatic cancer
            Science
            Humanities and Social Sciences
            multidisciplinary
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F4671053a/MediaObjects/41586_2010_Article_BF4671053a_Fig1_HTML.jpg
         isPartOf:
            name:Nature
            issn:
               1476-4687
               0028-0836
            volumeNumber:467
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:E. Georg Luebeck
               affiliation:
                     name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
                     address:
                        name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:NewsArticle
      context:https://schema.org
NewsArticle:
      headline:Genomic evolution of metastasis
      description:Prognosis for patients with pancreatic cancer is bleak, often owing to late diagnosis. The estimate that at least 15 years pass from tumour initiation to malignancy offers hope for early detection and prevention. See Letters p.1109 & p.1114 Christine Iacobuzio-Donahue and colleagues use whole-genome exome sequencing to analyse primary pancreatic cancers and one or more metastases from the same patients, and find that tumours are composed of distinct subclones. The authors also determine the evolutionary maps by which metastatic cancer clones have evolved within the primary tumour, and estimate the timescales of tumour progression. On the basis of these data, they estimate a mean period of 11.8 years between the initiation of pancreatic tumorigenesis and the formation of the parental, non-metastatic tumour, and a further 6.8 years for the index metastasis clone to arise. These data point to a potentially large window of opportunity during which it might be possible to detect the cancer in a relatively early form. Peter Campbell and colleagues use next-generation sequencing to detect chromosomal rearrangements in 13 patients with pancreatic cancer. The results reveal considerable inter-patient heterogeneity and indicate ongoing genomic instability and evolution during the development of metastases. But for most of the patients studied, more than half of the genetic rearrangements found were present in all metastases and the primary tumour, making them potential targets for therapeutic intervention at early and late stages of the disease.
      datePublished:2010-10-27T00:00:00Z
      dateModified:2010-10-27T00:00:00Z
      pageStart:1053
      pageEnd:1055
      sameAs:https://doi.org/10.1038/4671053a
      keywords:
         Cancer genomics
         Cancer prevention
         Genomic instability
         Pancreatic cancer
         Science
         Humanities and Social Sciences
         multidisciplinary
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2F4671053a/MediaObjects/41586_2010_Article_BF4671053a_Fig1_HTML.jpg
      isPartOf:
         name:Nature
         issn:
            1476-4687
            0028-0836
         volumeNumber:467
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:E. Georg Luebeck
            affiliation:
                  name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
                  address:
                     name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Nature
      issn:
         1476-4687
         0028-0836
      volumeNumber:467
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
      address:
         name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:E. Georg Luebeck
      affiliation:
            name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected]
            address:
               name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
               type:PostalAddress
            type:Organization
PostalAddress:
      name:E. Georg Luebeck is at the Fred Hutchinson Cancer Research Center, Program in Computational Biology, Seattle, Washington 98109-1024, USA. [email protected],
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {πŸ”—}(29)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

3.68s.